New insights into the survival mechanisms of rifampicin-resistant Mycobacterium tuberculosis

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 3, 2016, Pages 655-660

  Loots, Du Toit ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITATE HYDRATASE; ACONITIC ACID; MESSENGER RNA; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL SURVIVAL; ENZYME STABILITY; GENE MUTATION; METABOLOMICS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RIFAMPICIN RESISTANT MYCOBACTERIUM TUBERCULOSIS; RNA BINDING; TIME OF FLIGHT MASS SPECTROMETRY; DRUG EFFECTS; HUMAN; MASS SPECTROMETRY; METABOLISM; MICROBIAL VIABILITY;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MASS SPECTROMETRY; METABOLIC NETWORKS AND PATHWAYS; METABOLOMICS; MICROBIAL VIABILITY; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN;

EID: 84960815097     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv406     Document Type: Article

References (33)

1. Sudre P, ten Dam G, Kochi A. Tuberculosis: a global overview of the situation today. Bulletin World Health Organ 1992; 70: 149-59.
2. WHO. Global Tuberculosis Report 2014. WHO/HTM/TB/2014.08. Geneva: WHO Press, 2014.
3. Gillespie SH. Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob Agents Chemother 2002; 46: 267-74.
4. Aristoff PA, Garcia GA, Kirchhoff PD et al. Rifamycins-obstacles and opportunities. Tuberculosis 2010; 90: 94-118.
5. Morlock GP, Plikaytis BB, Crawford JT. Characterization of spontaneous, in vitro selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv. Antimicrob Agents Chemother 2000; 44: 3298-301.
6. Telenti A, Imboden P, Marchesi F et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341: 647-50.
7. Bilington OJ, McHugh TD, Gillespie SH. Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrob Agents Chemother 1999; 43: 1866-9.
8. Dennis PP, Nene V, Glass RE. Autogenous posttranscriptional regulation of RNA polymerase beta and beta' subunit synthesis in Escherichia coli. J Bacteriol 1985; 161: 803-6.
9. Anthony RM, Schuitema ARJ, Bergval IL et al. Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrumofmutations and elevated frequency. Ann Clin Microbiol Antimicrob 2005; 4: 9.
10. Bisson GP, Mehaffy C, Broeckling C et al. Upregulation of the phthiocerol dimycocerosate biosynthetic pathway by rifampicin-resistant rpoB mutant Mycobacterium tuberculosis. J Bacteriol 2012; 194: 6441-51.
11. WHO. WHO Report 2011: Global Tuberculosis Control. WHO/HTM/TB/2011.16. Geneva: WHO Press, 2011.
12. Gandhi NR, Moll A, Sturm AWet al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1575-80.
13. Wallengren K, Scano F, Nunn P et al. Drug-resistant tuberculosis, Kwazulu-Natal, South Africa, 2001-2007. Emerg Infect Dis 2011; 17: 1913-6.
14. Olivier I, Loots DT. A metabolomics approach to characterize and identify various Mycobacterium species. J Microbiol Methods 2012; 88: 419-26.
15. Schoeman JC, Du Preez I, Loots DT. A comparison of four sputum pre-extraction preparation methods for identifying and characterizing Mycobacterium tuberculosis using GCxGC-TOFMS metabolomics. J Microbiol Methods 2012; 91: 301-11.
16. Swanepoel C, Loots DT. The use of functional genomics in conjunction with metabolomics for Mycobacterium tuberculosis research. Dis Markers 2014; 2014: 124218.
17. Gagneux S, Long CD, Small PM et al. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 2006; 312: 1944-6.
18. Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009; 13: 1320-30.
19. Bergval I, Coll F, Schuitema A et al. A proportion of mutations fixed in the genomes of in vitro selected isogenic drug-resistant Mycobacterium tuberculosis mutants can be detected as minority variants in the parent culture. FEMS Microbiol Lett 2015; 362: 1-7.
20. Draisma HHM, Reijmers TH, Van der Kloet F et al. Equating or correction for between-block effects with application to body fluid LC-MS and NMR metabolomics data sets. Anal Chem 2010; 82: 1039-46.
21. Loots DT. An altered Mycobacterium tuberculosis metabolome induced by katG mutations resulting in isoniazid resistance. Antimicrob Agents Chemother 2014; 58: 2144-9.
22. Brereton RG. Chemometrics. Data analysis for the laboratory and chemical plant. J Chemometr 2003; 17: 360-1.
23. Chong IG, Jun CH. Performance of some variable selections methods when multicollinearity is present. Chemometr Intell Lab Syst 2005; 78: 103-12.
24. Bergval IL, Klatser PR, Schuitema ARJ et al. Specific mutations in the Mycobacterium tuberculosis rpoB gene are associated with increased dnaE2 expression. FEMS Microbiol Lett 2007; 275: 338-43.
25. Banerjee S, Nandyala AK, Raviprasad P et al. Iron-dependent RNA-binding activity of Mycobacterium tuberculosis aconitase. J Bacteriol 2007; 189: 4046-52.
26. Villela AD, Sánchez-Quitian ZA, Ducati RG et al. Pyrimidine salvage pathway in Mycobacterium tuberculosis. Curr Med Chem 2011; 18: 1286-98.
27. Du Preez I, Loots DT. Altered fatty acid metabolism due to rifampicinresistance conferring mutations in the rpoB gene of Mycobacterium tuberculosis: mapping the potential of pharmaco-metabolomics for global health and personalized medicine. OMICS 2012; 16: 596-603.
28. Du Preez I, Loots DT. New sputum metabolite markers implicating adaptions of the host to Mycobacterium tuberculosis, and vice versa. Tuberculosis 2013; 93: 330-7.
29. Gengenbacher M, Kaufmann SHE. Mycobacterium tuberculosis: success through dormancy. FEMS Microbiol Rev 2012; 36: 514-32.
30. Ramachandran S, Fontanille P, Pandey A et al. Gluconic acid: properties, applications and microbial production. Food Technol Biotechnol 2006; 44: 185-95.
31. Rhee KY, de Carvalho LPS, Bryk R et al. Central carbon metabolism in Mycobacterium tuberculosis: an unexpected frontier. Trends Microbiol 2011; 19: 307-14.
32. Greendryke R, Rajagopalan M, Parish T et al. Conditional expression of Mycobacterium smegmatis dnaA, an essential DNA replication gene. Microbiology 2002; 148: 3887-900.
33. Domenech P, Rog A, Moolji JU et al. The origins of a 350-kilobase genomic duplication in Mycobacterium tuberculosis and its impact on virulence. Infect Immun 2014; 82: 2902-12.